John Wegener is a distinguished commercial leader with over 20 years of experience driving transformative growth and operational excellence in the specialty diagnostics and therapeutics sectors. As Vice President of Sales at Mindera Health, John brings his strategic vision, market expertise, and proven leadership to advance the company’s mission of revolutionizing precision healthcare.

Prior to joining Mindera Health, John served as Senior Vice President of Sales and Marketing at Exagen Inc., where he played a pivotal role in scaling the company’s commercial operations. Under his leadership, annual revenue grew from $2 million to $55 million, driven by the disciplined expansion of sales teams, innovative market strategies, and the launch of eight new diagnostic products. John’s contributions also included securing high-profile collaborations with global leaders such as GSK and Janssen and playing a key role in Exagen’s successful IPO in 2019.

John’s career is marked by a strong focus on payer strategy, value-based pricing, and health economic modeling. Earlier in his career, he held progressive leadership roles at Prometheus Laboratories, contributing to revenue growth that propelled the company to industry prominence. His track record includes building and leading high-performing sales and managed care teams, as well as launching innovative products that transformed patient care in Gastroenterology, Rheumatology, and Oncology.

A graduate of The University of Arizona with a Bachelor of Science in Business Administration, John’s collaborative approach and commitment to achieving impactful outcomes position him as a dynamic leader in advancing Mindera Health’s vision.